Research class: Two-component receptor-signalling research blend.

This blend combines 5 mg CJC-1295 without DAC and 5 mg ipamorelin per vial. The components relate to GHRH-receptor and ghrelin-receptor signalling research, respectively.

Supplied as a 10 mg material for controlled receptor-signalling experiments and analytical characterization. This formulation contains no DAC; findings for long-acting DAC-linked compounds or the individual components do not establish the behaviour of this blend.

Supplied as lyophilized powder, 10 mg per vial. For in-vitro laboratory research only; not for use in humans or animals.

Material at a glance

• Declared content: 10 mg per vial
• Format: Lyophilized powder
• Product identifier: PF-CP10
• CJC-1295 (No DAC) — 5 mg
• Ipamorelin — 5 mg

Bigger isn’t always better.

Small production lots of 1,000 units or fewer. A new lot-specific certificate of analysis for every 1,000 units.

Developed, packaged and independently tested in the USA. Each arriving lot is held for testing. Products are released only after testing is complete and the lot’s COA is released and approved.

Preorders reserve incoming material. Dispatch follows completed testing and approved COA release.

explore our testing approach.

Analytical documentation

No lot-specific certificate is published for this SKU yet. A certificate for another strength or blend does not establish results for this material. Refer to the availability shown above for the current purchase status.

Declared content describes the product specification; measured content and purity are separate analytical results. Certificates apply to the sample and lot identified in the report.

RESEARCH USE ONLY — NOT FOR HUMAN OR ANIMAL USE. For legitimate laboratory research and analytical applications. Not intended for administration, consumption or clinical use.